NCT06558773 2026-02-11GSL Synthetase Inhibitor Plus Immune Checkpoint Inhibitor and/or Regorafenib in Previously Treated pMMR/MSS CRC.Chinese PLA General HospitalPhase 2 Recruiting120 enrolled
NCT07138547 2026-01-02GSL Synthetase Inhibitor Eliglustat Combined With CD30 Target Immunotherapy for the Treatment of of CD30+ LymphomaChinese PLA General HospitalPhase 1/2 Recruiting40 enrolled